CoreWeave's $129 Billion AI Backlog Changes the Bull Case

Key Points

• CoreWeave's Q2 revenue grew 113% year-over-year and its backlog topped $104 billion, sparking a sharp stock rally driven partly by short-covering.
• Technical factors and high short interest suggest CRWV could hit resistance around $115 to $125, even as analysts like JPMorgan raise price targets.
• Profitability hinges on converting the backlog to revenue and easing front-loaded capacity costs, with analysts projecting a path to positive margins by late 2027.

CoreWeave’s NASDAQ: CRWV Q2 results sparked a rally in its stock price and the broader market, as they reveal the AI spending bubble is still growing. Results were arguably tepid relative to consensus, with revenue outpacing the midpoint target by a mere 80 basis points, but the bar was set high.

The growth was exceptional. Critical details include the 113% year-over-year revenue growth, record-setting results, and a rapidly swelling backlog.

CoreWeave’s backlog topped $104 billion at quarter-end, which is compounded by an additional $25 billion in capacity contracted in early Q3, and is worth approximately 13 years' revenue at the Q2 pace. In this environment, all CoreWeave needs to do is execute its strategy. The company’s capital expenditure (CapEx) is accelerating as it accelerates the launch of new capacity.

In the company's recent earnings call, executives upped their year-end target for active power to 1.85 GW, a nearly 9% increase from the prior quarter. The likely outcome is that momentum continues to build, and subsequent releases are equally robust.

CoreWeave’s Bottom Is in, But Risks Remain

CoreWeave’s post-release price action triggered a 20% price increase in premarket trading, extending a move which began the day before the report came out. The takeaway is that CRWV is confirming solid support at the high $60 range and will likely continue advancing.

The risk is that this move is as much to do with short-covering, given the high short interest. MarketBeat data reveals more than 18% of shares were sold short as of early August, more than sufficient for short-covering to impact the price action. The question is how high the stock price might get before hitting its next ceiling, and the answer may not be all that high.

Technical factors suggest this stock could hit a ceiling in the $115 to $125 range. This range aligns with prior highs and congestion bands dating to just after the IPO and presents significant overhang. Additionally, technical indicators such as stochastic and MACD, which are bullish as of mid-August, have yet to show a firmly bullish entry signal; as of now, they align with range-bound trading. If short sellers remain interested, these are levels where they’re likely to sell into the rallies.

Analysts' sentiment trends are more bullish and set the stage for higher prices, but those prices won’t come easily. JPMorgan Chase lifted its price target to $110 following the earnings report, but commentary was generally cautious. Analysts at the firm highlight the obvious demand, swelling backlog, and aggressive scaling as near-term catalysts.

Other analysts chose to reaffirm their targets, pointing to cash burn, the balance sheet, swelling debt, and the impairment of interest expenses. CRWV remains well supported by analysts, with consensus pegged in the high $130-range, but may experience volatility due to short interest and general caution. Institutions can’t be relied on either, as they’ve slackened their accumulation to a trickle.

CoreWeave’s Catalyst: The Inflection to Positive Cash Flow

If CoreWeave’s biggest hurdle is the expense of building out capacity, the primary catalyst for higher share prices is executing on the backlog, converting it to revenue, and the transition to profitability. What the market gets wrong is that the bulk of CoreWeave’s expenses are front-loaded in the form of hardware and capacity expansion. These costs will diminish over time, rapidly as the build-out matures, leaving the long-term, cash-generating hyperscaler contracts in place.

Meanwhile, price hikes announced earlier this year were reflected in management's commentary. Executives see an accretive change in contract values and expect it to positively impact contributions, cash flow, and losses. In this scenario, the company’s margin will revert to positive and profitability could be reached by late 2027 or early 2028.

If the company continues accelerating deployment of active capacity, profitability could be reached much sooner. The biggest risk is the growing debt load; it takes a lot of money to buy GPUs and the adjacent hardware, and spending isn’t expected to slow soon. Delays and missteps will be reflected in the stock’s price, and dilution is always a threat.

Guidance is another factor for investors to consider. The company upped its guidance and may easily outperform it, but the forecast remains tepid relative to the consensus estimate. Analysts have set a high bar and may not be impressed with the upcoming results, regardless of their strength, unless there is clear evidence of cost control and glimmers of profitability. This sets the stage for CRWV share price action to remain range-bound within the existing range for the foreseeable future, potentially well into 2027.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source